Group 1 - The company has approved a proposal to change its registered capital and company type, which will be submitted for review at the upcoming shareholders' meeting [1][2] - The company has completed its initial public offering (IPO) of 90 million shares, increasing its total shares from 36,003.6657 million to 45,003.6657 million and its registered capital from 36,003.6657 million RMB to 45,003.6657 million RMB [1][2] - The company type has been changed from a foreign-invested, unlisted joint-stock company to a foreign-invested, listed joint-stock company [1][2] Group 2 - The company is revising its articles of association to enhance operational standards, in accordance with relevant laws and regulations, and will eliminate the supervisory board, transferring its responsibilities to the audit committee [2][3] - The revised articles will be effective upon approval at the shareholders' meeting, and the original articles will be automatically nullified [3] - The company will disclose the revised articles on the Shanghai Stock Exchange website after the shareholders' meeting [3]
广州必贝特医药股份有限公司关于变更公司注册资本、公司类型、修订《公司章程》并办理工商变更登记的公告